Instant Innovation In The Supply Chain
At the most recent Outsourced Pharma Boston conference, Anand Ekambaram, Executive Director, Global Technical Operations, Merck, posed this question to a panel of pharma and biotech executives:
This is the second of two articles based on the Outsourced Pharma Boston (April 26-27) conference session, Learning to Fly: How to Support Incremental Innovative Solutions.
“Is there a larger strategy directed at this kind of small “i” innovation? Because these innovations also bring risk with them. For example, the clinical developers are of the mindset, ‘Give me something that’ll work, that’s proven. Let’s get this product launched on time and reduce the risk as much as possible. We can save the improvements for the second generation.’”
Louis Garguillo, chief editor of outsourcedpharma.com and Conference Chair highlighted the exchange from executives from Biogen, Merck and others in this recent editorial, Instant Innovation In The Supply Chain. Read more for further insight into the discussion from the event.